脳磁図の世界市場2023年-2030年

【英語タイトル】Global Magnetoencephalography Market is Segmented By Application (Clinical, Dementia, Autism, Schizophrenia, Multiple Sclerosis, Stroke, Epilepsy, Others, Research), By End-user (Hospitals, Diagnostic Imaging centers, Academic and Research Institutes), and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030

DataM Intelligenceが出版した調査資料(DAM319MQ331)・商品コード:DAM319MQ331
・発行会社(調査会社):DataM Intelligence
・発行日:2024年7月
・ページ数:約180
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,350 ⇒換算¥626,400見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD4,850 ⇒換算¥698,400見積依頼/購入/質問フォーム
Enterprise User(法人閲覧用)USD7,850 ⇒換算¥1,130,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

he global Magnetoencephalography Market reached US$ 273.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 408.8 million by 2030. The global Magnetoencephalography market is expected to exhibit a CAGR of 5.2% during the forecast period (2023-2030).

Brain activity associated with many cognitive processes, including language processing, memory, attention, and sensory perception, can be mapped and localized using Magnetoencephalography. Researchers can learn more about how different parts of the brain interact and contribute to particular cognitive processes by examining the precise time and location of brain activity.

Magnetoencephalography Market Dynamics

The increasing prevalence of dementia is driving the global magnetoencephalography market growth.
Memory, conduct, emotional processing and control, and cognition are all significantly impacted by dementia, a type of degenerative brain condition. Alzheimer’s disease is the most prevalent kind of dementia, though there are other types as well. Worldwide, 55 million people currently living with dementia, and 10 million new cases are reported each year. In the future, this number will rise to 75 million in 2030 and 139 million in 2050. Developing nations will account for the majority of the increase.
People’s social and environmental situations, as well as their exposure to risk factors, frequently affect their mental health. Genetics, advanced age, tobacco, drug, and alcohol use, poor food, and physical inactivity are all risk factors for mental and neurological illnesses. People are also at danger from environmental exposures including pollution and cranial traumas.

Technological advancements are driving the global magnetoencephalography market growth.
The development of neuroimaging is perfectly positioned to enable the translation of advances in the cellular genetics and molecular biology of neurodegeneration into improved dementia diagnosis, treatment, and prevention. One of the key areas of advancement in neuroscience is the development of sophisticated neuroimaging techniques. Magnetic resonance imaging (MRI) has advanced greatly with the creation of functional MRI (fMRI) methods and high-resolution imaging. These advancements have enabled researchers to see brain activity in great detail and investigate the functional relationships between distinct brain areas.

Challenges associated with magnetoencephalography are hampering the global magnetoencephalography market growth.
MEG systems are less accessible than other neuroimaging methods like functional magnetic resonance imaging (fMRI) or electroencephalography (EEG) since they are pricey and highly specialized equipment. In addition to the initial purchase, MEG systems are expensive to operate, maintain, and staff with the necessary skills.
MEG infrastructure is not as common as other imaging modalities. It is difficult for researchers and clinicians to get access to MEG resources because of this limited availability, especially in some areas or healthcare settings. It might prevent MEG from being widely used in both research and therapeutic settings.

Magnetoencephalography Market Segment Analysis
The global magnetoencephalography market is segmented based on application, end-user, and region.

By Application
• [Clinical]
o Dementia
o Autism
o Schizophrenia
o Multiple Sclerosis
o Stroke
o Epilepsy
o Others
• [Research]

By End-user
• Hospitals
• Diagnostic Imaging centers
• Academic And Research Institutes

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa

❖ レポートの目次 ❖

  1. Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Definition and Overview

  3. Executive Summary

    1. Snippet by Application
    2. Snippet by End-user
    3. Snippet by Region
  4. Dynamics

    1. Impacting Factors
      1. Drivers
        1. The increasing incidence of dementia
      2. Restraints
        1. Challenges associated with magnetoencephalography
      3. Opportunity
        1. The increasing applications in clinical diagnostics
      4. Impact Analysis
  5. Industry Analysis

    1. Porter’s 5 Forces Analysis
    2. Supply Chain Analysis
    3. Unmet Needs
    4. Regulatory Analysis
  6. COVID-19 Analysis

    1. Analysis of COVID-19
      1. Scenario Before COVID-19
      2. Scenario During COVID-19
      3. Scenario Post COVID-19
    2. Pricing Dynamics Amid COVID-19
    3. Demand-Supply Spectrum
    4. Government Initiatives Related to the Market During the Pandemic
    5. Manufacturers’ Strategic Initiatives
    6. Conclusion
  7. Russia-Ukraine War Analysis
  8. Artificial Intelligence Analysis
  9. By Application

    1. Introduction
      1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      2. Market Attractiveness Index, By Application
    2. Clinical*
      1. Introduction
      2. Market Size Analysis and Y-o-Y Growth Analysis (%)
      3. Dementia
      4. Autism
      5. Schizophrenia
      6. Multiple Sclerosis
      7. Stroke
      8. Epilepsy
      9. Others
    3. Research
  10. By End-user

    1. Introduction
      1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
      2. Market Attractiveness Index, By End-user
    2. Hospitals*
      1. Introduction
      2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    3. Diagnostic Imaging centers
    4. Academic and Research Institutes
  11. By Region

    1. Introduction
      1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
      5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
      5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
      5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia-Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
      5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia-Pacific
    6. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  12. Competitive Landscape

    1. Competitive Scenario
    2. Product Benchmarking
    3. Company Share Analysis
    4. Key Developments and Strategies
  13. Company Profiles

    1. Compumedics Limited*
      1. Company Overview
      2. Product Portfolio and Description
      3. Financial Overview
      4. Key Developments
    2. MEGIN
    3. Ricoh USA, Inc.
    4. CTF MEG INTERNATIONAL SERVICES LP
    5. FieldLine Inc.
    6. Cerca Magnetics Limited
    7. Croton healthcare (*LIST NOT EXHAUSTIVE)
  14. Appendix

    1. About Us and Services
    2. Contact Us


★調査レポート[脳磁図の世界市場2023年-2030年] (コード:DAM319MQ331)販売に関する免責事項を必ずご確認ください。
★調査レポート[脳磁図の世界市場2023年-2030年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆